A recently published IMPACT-HD ( Integrating Proctoscopic Assessment With Patient Experience of Micronized Purified Flavonoid Fraction in Treatment of Grade I–II Hemorrhoids) study has shown effective improvements in clinical signs on proctoscopic assessment (redness, swelling, and bleeding) and in quality of life (QoL), following the administration of Micronized Purified Flavonoid Fraction (MPFF) in Indian patients with Grade I-II hemorrhoids.

These findings, published in the September 2025 issue of the Journal of Surgery , support MPFF as a safe, non-invasive first-line therapy for the management of Hemorrhoidal Disease (HD).

Hemorrhoidal disease (HD) is common and distressing anorectal condition, a frequent cause of patient visits to both primary care and specialist clinics, impac

See Full Page